Superior control of inflammatory pain by corticotropin-releasing factor receptor 1 via opioid peptides in distinct pain-relevant brain areas
Abstract Background Under inflammatory conditions, the activation of corticotropin-releasing factor (CRF) receptor has been shown to inhibit pain through opioid peptide release from immune cells or neurons. CRF’s effects on human and animal pain modulation depend, however, on the distribution of its...
Main Authors: | Shaaban A. Mousa, Baled I. Khalefa, Mohammed Shaqura, Mohammed Al-Madol, Sascha Treskatsch, Michael Schäfer |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-06-01
|
Series: | Journal of Neuroinflammation |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12974-022-02498-8 |
Similar Items
-
The Role of Corticotropin-Releasing Hormone at Peripheral Nociceptors: Implications for Pain Modulation
by: Haiyan Zheng, et al.
Published: (2020-12-01) -
Corticotropin-Releasing Hormone: Biology and Therapeutic Opportunities
by: Alessandra Caruso, et al.
Published: (2022-12-01) -
The role of the corticotropin-releasing hormone and its receptors in the regulation of stress response
by: E. V. Sukhareva
Published: (2021-04-01) -
Hypothalamic Regulation of Corticotropin-Releasing Factor under Stress and Stress Resilience
by: Kazunori Kageyama, et al.
Published: (2021-11-01) -
Effect of Intraparaventricular Administration of Corticotropin Releasing Hormone on Food Intake in Food-Deprived Rats
by: Atefeh Rayatpour, et al.
Published: (2017-08-01)